Methyldopa‐induced systemic lupus erythematosus
- 1 February 1989
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 32 (2) , 205-208
- https://doi.org/10.1002/anr.1780320214
Abstract
Thirteen months after starting methyldopa therapy, a 55‐year‐old white male patient presented with a syndrome of hemolytic anemia, arthritis, photosensitivity, and a positive antinuclear antibody test result. Methyldopa‐induced antinuclear antibodies were mainly IgG, directed against class H1 histones. Antibodies to native DNA and nonhistone proteins were not detected. Upon withdrawal of methyldopa therapy, and with a short course of prednisone and danazol therapy, the patient's symptoms and hemolytic anemia resolved. His clinical symptoms and serologic abnormalities returned to normal and remained negative after 2 years of followup.This publication has 19 references indexed in Scilit:
- Autoantigenic histone epitopes: a comparison between procainamide‐ and hydralazine‐induced lupusArthritis & Rheumatism, 1987
- Impaired Reticuloendothelial Function in Patients Treated with MethyldopaNew England Journal of Medicine, 1985
- IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupusClinical Immunology and Immunopathology, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982
- Reactivity of anti-histone antibodies induced by procainamide and hydralazineClinical Immunology and Immunopathology, 1982
- Lupus-like syndrome induced by methyldopa.BMJ, 1982
- Pharmacogenetic studies on the drug‐related lupus syndrome. differences in antinuclear antibody development and drug‐induced DNA damage in rapid and slow acetylator animal modelsArthritis & Rheumatism, 1981
- Methyldopa Inhibition of Suppressor-Lymphocyte FunctionNew England Journal of Medicine, 1980
- Antibodies to Histones in Drug-Induced and Idiopathic Lupus ErythematosusJournal of Clinical Investigation, 1978
- Effect of Acetylator Phenotype on the Rate at Which Procainamide Induces Antinuclear Antibodies and the Lupus SyndromeNew England Journal of Medicine, 1978